Reuters: Vaccine alliance backs typhoid shots for poor with $85 million
“The Gavi global vaccine alliance has earmarked $85 million to help support the introduction of typhoid vaccines in poor countries where millions of children are at risk of the often deadly disease. The funds, agreed by GAVI at a meeting on Thursday, will go towards bulk-buying of new typhoid vaccines including one developed by privately held Bharat Biotech, the alliance said in a statement…” (Kelland, 11/30).